Okyo PharmaOKYO
13F holders, Q1 2026 (March 31)12holders +2
4new positions
2sold out
$1.61avg. 13F price*
At the end of Q1 2026, 12 institutions reported holding Okyo Pharma Ltd. (OKYO) in their 13F filings, up 2 from Q4 2025. 4 opened new positions and 2 sold out. The largest holders were Woodline Partners LP ($5.9M), Maven Securities LTD ($1.9M) and Stonepine Capital Management, LLC ($1.4M).
- Company
- Okyo Pharma Ltd.
- CUSIP
- G6724L116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $10.1M |
| Exits | 2 | $307K |
All 13F filers, Q4 2025 → Q1 2026: 6,340,149 shares bought and 615,704 shares sold, net +5,724,445 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Woodline Partners LP | 0.02% | New | 3,652,190 | $5.9M |
| Maven Securities LTD | 0.11% | New | 1,175,535 | $1.9M |
| Stonepine Capital Management, LLC | 1.20% | New | 850,000 | $1.4M |
| Balyasny Asset Management L.P. | 0.00% | New | 584,796 | $942K |
| UBS Group AG | 0.00% | Add +2651.4% | 59,760 | $96K |
| XTX Topco Ltd | 0.00% | Add +113.8% | 37,652 | $61K |
| Cerity Partners LLC | 0.00% | No change | 12,812 | $21K |
| Geode Capital Management, LLC | 0.00% | No change | 12,090 | $19K |
| Dauntless Investment Group, LLC | 0.02% | Reduce -99.2% | 3,819 | $6K |
| EFG International AG | 0.00% | No change | 923 | $1K |
| Osaic Holdings, Inc. | 0.00% | No change | 152 | $244 |
| Morgan Stanley | 0.00% | No change | 10 | $16 |
"% of holder's portfolio" is OKYO's weight in each manager's 13F, not the share of Okyo Pharma Ltd. the manager owns.